文献速递前列腺增生与排尿功能障碍小儿泌尿与泌尿修复

骶神经调控对可走动脊柱裂患者神经源性膀胱与肠道功能障碍的疗效

The Effect of Sacral Neuromodulation in Ambulatory Spina Bifida Patients with Neurogenic Bladder and Bowel Dysfunction.
PubMed 文献 · Urology · 2021-02-06

本研究回顾性分析29例接受骶神经调控测试的可走动脊柱裂合并神经源性膀胱与肠道功能障碍患者。测试期21例(72.4%)至少1项症状改善,慢性尿潴留成功率(26.09%)显著低于尿急-尿频综合征(58.82%)和尿失禁(56.25%),神经源性肠道功能障碍评分从13.3±6.29降至6.9±5.09(P<.0001),最大膀胱测压容量、顺应性和最大逼尿肌压力显著改善(P<.05)。16例(55.17%)植入,慢性尿潴留是显著风险因素(P<.05)。

要点

  • SNM测试期72.4%患者至少1项症状改善,慢性尿潴留成功率显著低于尿急-尿频和尿失禁。
  • SNM显著降低神经源性肠道功能障碍评分并改善储尿期尿动力学参数。
  • 慢性尿潴留是SNM疗效的显著负性风险因素。

核心结论

  • SNM对可走动脊柱裂患者的神经源性膀胱与肠道功能障碍有效,尤其适用于无慢性尿潴留者。
  • SNM可显著改善此类患者储尿期的尿动力学参数。

研究设计与样本

  • 回顾性研究,纳入2012年7月至2020年1月接受SNM测试的29例可走动脊柱裂合并神经源性膀胱与肠道功能障碍患者。
  • 收集临床数据和影像尿动力学参数,采用t检验和卡方检验比较,并以logistic回归分析潜在风险因素,P<.05为显著。

主要发现

  • 测试期21例(72.4%)至少1项症状成功改善。
  • 慢性尿潴留成功率(26.09%)显著低于尿急-尿频综合征(58.82%)和尿失禁(56.25%)(P<.05)。
  • 神经源性肠道功能障碍评分从13.3±6.29降至6.9±5.09(P<.0001)。
  • 尿动力学评估显示平均最大膀胱测压容量、顺应性和最大逼尿肌压力显著改善(P<.05)。
  • 16例(55.17%)接受植入;风险分析显示慢性尿潴留是统计学显著变量(P<.05)。

关键数值与推荐

  • 测试期无并发症报告。
  • 平均随访时间41.19±33.06个月。
  • 2例改为间歇导尿,2例改为膀胱扩大术。

临床怎么用

  • 对可走动脊柱裂合并神经源性膀胱与肠道功能障碍患者,SNM是可考虑的治疗选择。
  • 术前应评估是否存在慢性尿潴留,因其与较低的SNM测试成功率相关。

局限性

  • 回顾性研究,样本量29例,可能存在选择偏倚。
  • 单中心研究,随访时间变异较大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effect of sacral neuromodulation (SNM) in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction. MATERIALS AND METHODS: We retrospectively reviewed the records of 29 ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction who underwent SNM testing from July 2012 to January 2020. Clinical data and video-urodynamic parameters were collected and compared using the t-test and the chi-square test. The potential risk factors were considered by logistic regression analysis. P < .05 was considered significant. RESULTS: In the test phase, 21 patients (72.4%) achieved successful improvement of at least 1 symptom. The success rate for chronic urinary retention (26.09%) was significantly lower (P <.05) than that for urgency-frequency syndrome (58.82%) and urinary incontinence (56.25%). The mean neurogenic bowel dysfunction score decreased from 13.3±6.29 to 6.9±5.09 (P <.0001). The urodynamic evaluation showed a significant improvement in the mean maximum cystometric capacity, compliance, and maximum detrusor pressure (P <.05). Implantation was performed in 16 cases (55.17%). The analysis of the risk factors showed that chronic urinary retention was a statistically significant variable (P <.05). No complications were reported in the test phase. The average follow-up time was 41.19±33.06 months. Two patients changed to intermittent catheterization, and 2 patients changed to augmentation cystoplasty. CONCLUSION: SNM is effective for neurogenic bladder and bowel dysfunction in patients with ambulatory spina bifida, especially in those without chronic urinary retention. And SNM can also significantly improve the urodynamic parameters of these patients during the storage period.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Chen G, Liao L, Deng H, et al. The Effect of Sacral Neuromodulation in Ambulatory Spina Bifida Patients with Neurogenic Bladder and Bowel Dysfunction. Urology. 2021. PMID: 33556449. doi:10.1016/j.urology.2020.11.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。